SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing significant selling pressure as investors grapple with concerns over high capital expenditures in AI infrastructure and potential execution risks, fueling a volatile debate in the community about whether this represents a long-term value opportunity or a structural decline. While some traders are expressing extreme frustration over the stock's persistent underperformance relative to broader market indices, others are highlighting the company's strong cash flows and cloud leadership as reasons to view current price levels as an attractive entry point for the long term.

The Shrimp Army

The Shrimp Army is gaining traction as part of a broader trend of sea-themed memecoins, sparking intense debate among community members over its potential for rapid growth versus risks of being a speculative pump-and-dump. Traders are actively monitoring the token's ability to maintain upward momentum and consolidate at higher valuation levels.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing significant downward pressure as investors react to a Google Research blog post regarding TurboQuant, an algorithmic compression method that some fear could reduce long-term demand for high-bandwidth memory. While the broader community is deeply divided between those viewing the sell-off as an algorithmic panic driven by misunderstanding and those concerned about cyclical memory sector headwinds, many retail traders are actively debating whether to accumulate shares on the dip or exit to avoid further downside.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is facing intense selling pressure as investors react to potential regulatory hurdles regarding prediction markets and ongoing legal challenges surrounding the NCAA. The community is heavily polarized, with many retail traders actively loading puts and voicing frustration over consistent insider selling while others view the pullback as a potential buying opportunity.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

Adma Biologics is currently in the spotlight following a short-seller report from Culper Research that alleges channel stuffing and financial irregularities, which the company has formally dismissed as containing misleading and inaccurate statements. The community is actively debating the credibility of these allegations, with many long-term shareholders expressing strong conviction in management's integrity and focusing on upcoming earnings as a potential catalyst for a rebound.

PRIME is the native token of the Echelon Prime Foundation, a Web3 ecosystem advancing the next generation of gaming. Echelon creates and distributes tools to encourage innovation in, and promote the growth of, novel gaming models and economies. The first game to adopt and utilize PRIME is Parallel, a sci-fi trading card game.

Echelon Prime

Echelon Prime is trending as community members point to signs of quiet accumulation and a potential bullish reversal for the gaming token. Traders are actively debating the token's role in the future of on-chain gaming economies, with sentiment divided between optimism for a recovery and frustration over recent volatility.

Fundrise Growth Tech Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is trending as investors debate whether the fund's parabolic run is driven by genuine exposure to high-growth AI and aerospace giants like SpaceX and Anthropic or if it has entered bubble territory due to its massive premium to Net Asset Value. The community remains sharply divided, with many actively hunting for alternative "catch-up" plays like DXYZ and RVI while others warn of a potential liquidity trap once lock-up periods expire.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is seeing heightened trading volume and community interest driven by persistent speculation regarding an upcoming SpaceX IPO, which remains a primary holding for the fund. Investors are actively debating the valuation premium relative to its net asset value compared to other proxies, while sentiment remains bullish on the fund's concentrated exposure to high-growth unicorns like Anthropic and OpenAI.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending as investors react to the launch of Costco's private-label energy drink, which has sparked heated debate over potential market share erosion and the strength of the brand's moat. While some in the community see the sell-off as an emotional overreaction and a buying opportunity, others are expressing concern over cooling growth data and perceived management failures, leading to significant volatility.

Navan, Inc. engages in offering a cloud-based technology platform for travelers. Its products include business travel and expense management. The company was founded by Ariel Cohen and Ilan Twig in February 2015 and is headquartered in Palo Alto, CA.

Navan Inc. - Ordinary Shares - Class A

Navan shares are seeing significant volatility as investors digest a string of strong earnings results and upbeat fiscal outlooks, while the broader community debates whether the AI-integrated platform is a long-term disruptor or facing undue selling pressure. Much of the active discussion centers on the company's recent margin expansion and revenue growth versus persistent concerns regarding its IPO performance and general market sentiment toward SaaS-based travel tech.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Abivax CEO Downplays Sale Talk, Eyes Capital Raise As Key Trial Data Readout Nears

Abivax plans fundraising after June trial data as CEO signals no urgency to sell amid takeover speculation and strong stock momentum.read more...

Abivax in no rush for a deal, confident key June trial data can secure better terms for partnerships, CEO tells CNBC

Analysts see the biotech company as a prime takeover target and several pharma giants have been rumored as potential buyers...

Barclays Raises Abivax (NASDAQ:ABVX) Price Target to $148.00

Barclays upped their price target on Abivax from $142.00 to $148.00 and gave the stock an "overweight" rating in a report on Tuesday...

Abivax (NASDAQ:ABVX) Announces Earnings Results

Abivax (NASDAQ:ABVX - Get Free Report) issued its quarterly earnings results on Monday. The company reported ($1.24) earnings per share for the quarter, topping the consensus estimate of ($2.24) by...

Hudson Bay Capital Management LP Makes New Investment in Abivax SA Sponsored ADR $ABVX

Hudson Bay Capital Management LP purchased a new stake in Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 91,062 shares of the company's stock, valued a...

35,000 Shares in Abivax SA Sponsored ADR $ABVX Bought by Cantor Fitzgerald L. P.

Cantor Fitzgerald L. P. acquired a new stake in Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 35,000 shares of the company's stock, valued at approximately $2...

Holocene Advisors LP Buys Shares of 461,301 Abivax SA Sponsored ADR $ABVX

Holocene Advisors LP bought a new stake in Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and...

Top Biotech Stocks To Keep An Eye On - March 16th

Danaher, Vertex Pharmaceuticals, Moderna, BioCryst Pharmaceuticals, ImmunityBio, argenex, and Abivax are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...

Abivax (NASDAQ:ABVX) Now Covered by Jefferies Financial Group

Jefferies Financial Group assumed coverage on Abivax in a research note on Monday. They set a "buy" rating and a $160.00 target price for the company...

HighVista Strategies LLC Raises Holdings in Abivax SA Sponsored ADR $ABVX

HighVista Strategies LLC boosted its holdings in Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) by 260.6% during the 3rd quarter, according to the company in its most recent disclosure with the...

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

ABVX
Abivax - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABVX News

ABVXAbivax - ADR